| Value | ₹0.01 Cr |
|---|
NSE filing, NSE: TMPV. Summary written from the filing by ALFA Finder's alert engine.
Tata Motors Passenger Vehicles Ltd: key numbers
- Share price
- ₹263.60
- Market cap
- ₹97,084 Cr
- Revenue (annual)
- ₹3,35,582 Cr
- Net profit (annual)
- ₹82,390 Cr
- P/E (TTM)
- 1.2×Sector 30.9×
- Promoter holding
- 42.50%-0.01% QoQ
- FII holding
- 15.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Motors Passenger Vehicles Ltd
All →Tata Motors Passenger Vehicles Board Meeting Date
Tata Motors Passenger Vehicles will hold a board meeting on 13 November 2026 to approve Q2 and half-year results. An analyst call follows the results announcement.
Tata Motors Passenger Vehicles Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine periodic disclosure mandated by SEBI regulations.
Tata Motors Passenger Vehicles Partnership
TMPV and Stellantis sign a Definitive Agreement expanding their partnership into advanced vehicle technology collaboration. Vehicles will be built at their 50:50 JV, FIAPL, for global markets.
Tata Motors Passenger Vehicles Debt & Borrowing
Tata Motors Passenger Vehicles filed its half-yearly debt securities compliance report as of September 30, 2026. The filing details three outstanding NCD tranches maturing in 2028.
Tata Motors Passenger Vehicles Business Update
Tata Motors Passenger Vehicles recorded sales of 201,723 units in Q2 FY27, marking 40% year-on-year growth. EV sales grew 90% to over 47,000 units during the quarter.
- quarterly sales volume
- 201723.0 units
Tata Motors Passenger Vehicles Price Movement Clarification
Tata Motors Passenger Vehicles clarified that it has no knowledge of any negotiations mentioned in the news report regarding the company.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date